From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

A jab given to patients to battle RSV through the NHS could potentially cause a disabling condition known as Guillain-Barré ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

A new vaccine offered to millions of pensioners ... said results of an American study suggested two types of RSV jab carry a significant increased risk of Guillain-Barré syndrome — a disabling ...

Dec. 23, 2024 — A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, ... Scientists Design ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

Pregnant women across the Northern Territory now have free access to protection against a virus that is the leading cause of hospitalisation for babies. The federal government is investing $174.5m ...

(MENAFN- The Conversation) From today, February 3 , pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation Program . This vaccine is designed to ...

From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation Program. This vaccine is designed to protect young infants from severe ...